Search Within

Alexander Noor Shoushtari

  1. "Sarcoma Surgeons"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
  3. Research Letter (1)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Hematologic Malignancies, Division of (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Melanoma Disease Management Team (7)
  6. Melanoma and Immunotherapeutics Service (7)

More Groups

People
  1. William Tap (5)
  2. Marc Ladanyi (4)
  3. Ping Chi (4)
  4. Samuel Singer (4)
  5. Abraham Hakimi (3)
  6. Ahmet Zehir (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2019 (1)
  5. 2016 (1)
  6. 2015 (1)
Publications
  1. Cell (1)
  2. Investigational New Drugs (1)
  3. Journal of Clinical Oncology (1)
  4. Modern Pathology (1)
  5. Nature Communications (1)
  6. Nature Genetics (1)

More Publications

Publishers
  1. Nature Publishing Group (2)
  2. American Society of Clinical Oncology (1)
  3. Cell Press (1)
  4. Hindawi Publishing Corporation (1)
  5. Nature Research (1)
  6. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: Mutational signature analysis and immunotherapy response
    Journal Article

    Kasago, I. S.; Chatila, W. K.; Lezcano, C. M.; Febres-Aldana, C. A.; Schultz, N.; Vanderbilt, C.; Dogan, S.; Bartlett, E. K.; D'Angelo, S. P.; Tap, W. D.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • The association between tumor mutational burden and prognosis is dependent on treatment context
    Research Letter

    Valero, C.; Lee, M.; Hoen, D.; Wang, J.; Nadeem, Z.; Patel, N.; Postow, M. A.; Shoushtari, A. N.; Plitas, G.; Balachandran, V. P.; more...
    Nature Genetics (2021)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Overall survival and response to systemic therapy in metastatic extrauterine leiomyosarcoma
    Journal Article

    Shoushtari, A. N.; Landa, J.; Kuk, D.; Sanchez, A.; Lala, B.; Schmidt, N.; Okoli, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; more...
    Sarcoma (2016)

    Fulltext@MSK | Save
  • A phase Ib/II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Shoushtari, A. N.; Condy, M. M.; Konen, T.; Fruauff, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save